U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06878469) titled 'SIMPLIFication of Care Pathways for Patients with Rare Brain Tumors Through Artificial Intelligence' on Jan. 30.
Brief Summary: This study focuses on rare brain tumors, which are heterogeneous entities with different morphological, biological, and clinical characteristics. Due to their rarity, many of these tumors fall under the RARECARE definition of rare tumors. The main objective of the study is to standardize care models and pathways for patients with rare brain tumors, using Artificial Intelligence (AI) and Machine Learning (ML) techniques to identify specific predictors of postoperative outcomes.
The study includes both retr...